Stephen Ray’s recent article in the (Premiergazette) entitled “Dr. Mark Holterman is Changing the Way Medicine is Practiced Everywhere” reveals that Dr. Holterman is founder and CEO of Mariam Global Health, which examines medical startup companies in order to find those with the greatest potential, and funds them sufficiently to follow through with their ideas. Dr. Holterman stays in touch with these chosen companies, and shares with them his expertise in keeping costs at a very reasonable level, so that the startups are prepared in the event that investors change their minds on providing the money they originally promised to them.
Dr. Mark Holterman holds Ph.D. and M.D. degrees from the University of Virginia in Immunology and Medicine, and is a pediatrician, board-certified pediatric surgeon, and professor of pediatrics and surgery, and he is particularly focused on studying autoimmunity and performing ethical stem cell research.
The article also describes how Dr. Mark Holterman donates much of his time and money to the International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN). The purpose of this charity is to strengthen Vietnam’s healthcare system by having surgeons volunteer their services, particularly in rural areas, and by providing medical equipment donated from the United States. IPSAC-VN’s main purpose is to serve as a teaching facility, enabling surgical students to receive their training in Vietnam, and bringing Vietnamese doctors to the U.S. to study for two months.
Dr. Mark Holterman is a member of the American Association of Clinical Anatomists, which seeks to tailor individualized medical treatment by developing a “virtual” human body which is more informative than superficial anatomical data and diagrams. He also is a member of the Pacific Association of Pediatric Surgeons, which has over 500 members in 23 countries, and he received the Innovative Research Award from the American Diabetes Association.
A longtime advocate of regenerative medicine, Dr. Mark Holterman explains that cellular therapies, where human stem cells are transplanted from bone marrow or fat to restore tissue, can be used to fight osteoarthritis and autoimmune disorders.